Trends of Lymph Node Outcomes in Partial Cystectomy for Muscle-Invasive Urothelial Carcinoma of the Bladder

被引:3
作者
Klose, Charles [2 ,3 ]
Gordon, Olivia
Sparks, Andrew [1 ]
Whalen, Michael
机构
[1] George Washington Univ, Dept Urol, Sch Med & Hlth Sci, Washington, DC USA
[2] East Carolina Univ, Brody Sch Med, Greenville, NC USA
[3] GWU Med Fac Associates, Dept Urol, 2150 Penn Ave NW, Suite 3-417sb, Washington, DC 20037 USA
关键词
Bladder Cancer; Pelvic Lymph Node Dissection; Regional Nodes Examined; Bladder Sparing; Node Yield; RADICAL CYSTECTOMY; CANCER;
D O I
10.1016/j.clgc.2023.05.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Local tumor invasion depth has been associated with lymph node metastasis in urothelial carcinoma, and, for muscle-invasive bladder cancer (MIBC), pelvic lymph node dissection (PLND) is a critical step in curative surgery. Gold standard treatment includes radical cystectomy (RC), but partial cystectomy (PC) is an important bladder -preserving modality reserved for patients with certain favorable prognostic indicators. There is poor evidence concerning the utility of PLND in PC and we seek to further define its role by comparing survival outcomes when PLND was cursory or omitted. Methods: A retrospective analysis of 13,652 cT2N0M0 patients who underwent PC or RC between 2004 and 2016 was performed using the National Cancer Database. Patients undergoing PC were stratified by the presence of PLND as well as by node yield > 15. The primary outcome was overall survival, analyzed using the Kaplan-Meier Method and multivariable Cox-proportional hazards regression. Multivariable models were adjusted for confounding clinicopathologic variables. Results: From 2004 to 2016, PLND in PC increased from 44% to 57% with RC remaining over 90%. Compared to RC, PC was approximately twice as likely to be performed at community centers and approached laparoscopically/robotically ( P < .001). When stratifying PC PLND yield into 1 to 15 and > 15 compared to PC without PLND, the adjusted hazard ratios for overall mortality were 0.78 and 0.54, respectively ( P < .05). Conclusions: PC patients had a significantly lower rate of PLND compared to RC and improved survival when performed versus PC alone. Furthermore, increased node yield was associated with a larger reduction of adjusted mortality hazard. For MIBC patients that are appropriately selected for PC, high-yield PLND should be pr ior itized given the significantly improved survival outcomes.
引用
收藏
页码:703 / 709
页数:7
相关论文
共 50 条
[41]   Immunohistochemical Algorithm for the Classification of Muscle-Invasive Urinary Bladder Carcinoma with Lymph Node Metastasis: An Institutional Study [J].
Beatriz Pena, Karla ;
Riu, Francesc ;
Guma, Josep ;
Martinez-Madueno, Francisca ;
Miranda, Maria Jose ;
Vidal, Anna ;
Grifoll, Marc ;
Badia, Joan ;
Rodriguez-Balada, Marta ;
Parada, David .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
[42]   Therapy for Muscle-Invasive Urothelial Carcinoma: Controversies and Dilemmas [J].
Sonpavde, Guru P. ;
Mouw, Kent W. ;
Mossanen, Matthew .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (12) :1275-+
[43]   Clinical Outcomes in Patients With Muscle-Invasive Urothelial Carcinoma Treated With Nivolumab [J].
Barragan-Carrillo, Regina ;
Ebrahimi, Hedyeh ;
John, William S. ;
Lucht, Sarah ;
Miller, Taavy A. ;
Pathak, Prathamesh ;
Bland, Emily ;
Gordon, Sarah ;
Laney, JaLyna ;
Klink, Andrew J. ;
Feinberg, Bruce ;
Singh, Nisha ;
Alonso, Carmelo ;
Patel, Miraj Y. ;
Rosenblatt, Lisa ;
Yin, Xin ;
Chehrazi-Raffle, Alexander .
JAMA NETWORK OPEN, 2025, 8 (06)
[44]   Temporal Trends and Cancer-Specific Mortality in Nonmetastatic Muscle-Invasive Urothelial Carcinoma of the Urinary Bladder Treated With Trimodal Therapy [J].
de Angelis, Mario ;
Scheipner, Lukas ;
Siech, Carolin ;
Jannello, Letizia Maria Ippolita ;
Baudo, Andrea ;
Di Bello, Francesco ;
Goyal, Jordan A. ;
Vitucci, Kira ;
Tian, Zhe ;
Longo, Nicola ;
Ahyai, Sascha ;
de Cobelli, Ottavio ;
Chun, Felix K. H. ;
Saad, Fred ;
Shariat, Shahrokh F. ;
Carmignani, Luca ;
Gandaglia, Giorgio ;
Moschini, Marco ;
Montorsi, Francesco ;
Briganti, Alberto ;
Karakiewicz, Pierre I. .
CLINICAL GENITOURINARY CANCER, 2024, 22 (04)
[45]   Sentinel lymph node biopsy in muscle-invasive bladder cancer: single-center experience [J].
Zarifmahmoudi, Leili ;
Ghorbani, Hamidreza ;
Sadeghi, Ramin ;
Sadri, Kayvan ;
Tavakkoli, Mahmoud ;
Keshvari, Maliheh ;
Salehi, Maryam .
ANNALS OF NUCLEAR MEDICINE, 2020, 34 (10) :718-724
[46]   Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma [J].
Achkar, Tala ;
Parikh, Rahul A. .
UROLOGIC CLINICS OF NORTH AMERICA, 2018, 45 (02) :257-+
[47]   Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resection [J].
Morton, Ernest ;
Kaul, Sumedh ;
Fleishman, Aaron ;
Korets, Ruslan ;
Chang, Peter ;
Wagner, Andrew ;
Kim, Simon P. ;
Bellmunt, Joaquim ;
Kaplan, Irving ;
Olumi, Aria F. ;
Gershman, Boris .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) :255.e7-255.e14
[48]   Partial cystectomy for urothelial carcinoma of the bladder: Practice patterns and outcomes in the general population [J].
Leveridge, Michael J. ;
Siemens, D. Robert ;
Izard, Jason P. ;
Wei, Xuejiao ;
Booth, Christopher M. .
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (12) :412-418
[49]   The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma [J].
Shigeta, Keisuke ;
Matsumoto, Kazuhiro ;
Ogihara, Koichiro ;
Murakami, Tetsushi ;
Anno, Tadatsugu ;
Umeda, Kota ;
Izawa, Mizuki ;
Baba, Yuto ;
Sanjo, Tansei ;
Shojo, Kazunori ;
Tanaka, Nobuyuki ;
Takeda, Toshikazu ;
Kosaka, Takeo ;
Mizuno, Ryuichi ;
Mikami, Shuji ;
Kikuchi, Eiji ;
Oya, Mototsugu .
CANCER SCIENCE, 2021, 112 (03) :1084-1094
[50]   Lymphadenectomy for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma [J].
Sathianathen, Niranjan J. ;
Risk, Michael C. ;
Konety, Badrinath R. .
UROLOGIC CLINICS OF NORTH AMERICA, 2018, 45 (02) :215-+